FDA Adverse Event Injury Summary report: N

PRODIGY AUTOCODE

MDR report key: 5332174 · Received December 29, 2015

Report

Report Number
3005862821-2015-00018
Event Type
Injury
Date Received
December 29, 2015
Date of Event
November 15, 2015
Report Date
November 17, 2015
Manufacturer
OK BIOTECH CO., LTD.
Product Code
NBW
PMA / PMN Number
K073118
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SUSPECTED DEVICE EVALUATED BY OK BIOTECH AND CALCULATED THAT THE METER OPERATED WITHIN SPECIFICATIONS. THE STANDBY CURRENT TEST IS 16.4¿A. THE CRITERIA IS <55¿A. PASS. METER SETTING, AUDIO AND ALL BUTTONS FUNCTION ARE OK. TESTED THE SUSPECTED METER WITH IN HOUSE CONTROL SOLUTION AND IN HOUSE STRIPS (STRIP LOT NUMBER:D150923-1). THE CONTROL SOLUTION TESTS FOR LEVEL LOW ARE 61/59 MG/DL; FOR LEVEL HIGH ARE 274/280 MG/DL. THE CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS. PATIENT TOLD THAT THE STRIP LOT WITH THEM WAS LOT NUMBER D150730-2. BUT THE SUSPECTED STRIPS DID NOT RETURNED TO OK BIOTECH, SO WE TESTED THE RETAINED STRIPS IN OUR WAREHOUSE (STRIP LOT NUMBER:D150730-2). THE CONTROL SOLUTION TESTS FOR LEVEL LOW WERE 60/60 MG/DL; FOR LEVEL HIGH WERE 281/281 MG/DL. THE CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS.

Description of Event or Problem · 1

(B)(4) (OUR IMPORTER) RECEIVED A CALL ON (B)(6) 2015 REPORTING A MEDICAL INTERVENTION THAT OCCURED ON (B)(6) 2015 AT 8:00AM. PATIENT'S SPOUSE(CB) CALLED IN STATING THAT SHE PERFORMED A BLOOD GLUCOSE TEST ON PATIENT(TB) WITH A RESULT OF 300MG/DL. PATIENT WAS NOT DISPLAYING ANY SYMPTOMS. PATIENT'S SPOUSE CALLED BECAUSE OF BEING INSTRUCTED BY PATIENT'S PHYSICIAN TO REPORT INCIDENTS TO HIM/HER WHEN PATIENT'S BLOOD GLUCOSE LEVEL IS ABOVE 300MG/DL. EVENT HAPPENED ON SUNDAY, SO PATIENT CALLED EMS INSTEAD OF PATIENT'S PHYSICIAN. PATIENT'S BLOOD GLUCOSE READING AT THE TIME OF THE EVENT WAS 300MG/DL WITH THE PRODIGY METER. NO MEDICATION WAS TAKEN PRIOR TO THE EVENT. PATIENT'S NORMAL GLUCOSE READING AROUND THE TIME OF THIS EVENT IS AROUND 100MG/DL. PATIENT DRANK 7-UP PRIOR TO SEEKING MEDICAL ATTENTION. PARAMEDICS WERE CALLED WITHIN 1 HOUR AFTER TESTING WITH THE PRODIGY METER. PARAMEDICS ARRIVED AT PATIENT'S HOME WITHIN 15-20 MINUTES OF BEING CALLED. PARAMEDICS PERFORMED A BLOOD GLUCOSE TEST WITH THEIR METER WITH A RESULT OF 109MG/DL. APPROXIMATELY 1 HOUR HAD PASSED IN BETWEEN INITIAL TESTING WITH THE PRODIGY METER AND THE PARAMEDIC'S METER. PARAMEDICS ALSO PERFORMED A GLUCOSE TEST WITH THE PRODIGY METER WITH A RESULT OF AROUND 300-400MG/DL. WHILE WAITING ON PARAMEDICS PATIENT WAS BATHED AND PLACED IN A RECLINER. PARAMEDICS DID NOT ADMINISTER ANY TREATMENT. PATIENT WAS NOT TRANSPORTED TO HOSPITAL. NO CHANGES HAD BEEN MADE TO PATIENT'S DIABETIC MEDICATIONS BEFORE OR AFTER THE EVENT. ADDITIONAL NOTE: PATIENT PERFORMS GLUCOSE TEST 3 TIMES PER DAY VIA FINGERS. CONTROL SOLUTION TEST WAS PERFORMED BY CALLER ON THE DAY OF THE MEDICAL INTERVENTION AND RESULTS WERE WITHIN RANGE. PRODIGY PERFORMED 3 CONTROL SOLUTION TEST AND RESULTS WERE WITHIN RANGE. PDC IS FOLLOWING UP WITH REPORTER TO REQUEST RETURN OF SUSPECT SYSTEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
856269 PRODIGY AUTOCODE BLOOD GLUCOSE MONITORING DEVICE NBW OK BIOTECH CO., LTD. 51850

Patients

Seq Age Sex Outcome Treatment
1 80 YR Required Intervention 200-250 2 UNITS